Robinson, SP; McIntyre, DJ; Checkley, D; Tessier, JJ; Howe, FA; Griffiths, JR; Ashton, SE; Ryan, AJ; Blakey, DC; Waterton, JC (2003) Tumour dose response to the antivascular agent ZD6126 assessed by magnetic resonance imaging. BRITISH JOURNAL OF CANCER, 88 (10). 1592 - 1597 (6). ISSN 0007-0920 https://doi.org/10.1038/sj.bjc.6600926
SGUL Authors: Howe, Franklyn Arron

Preview

["document_typename_application/pdf; charset=binary" not defined] Published Version Download (167kB) | Preview

Item Type:	Article
Additional Information:	PubMed ID: 12771928
Keywords:	Science & Technology, Life Sciences & Biomedicine, Oncology, ZD6126, vascular targeting agents, MRI, tumour perfusion, response biomarker, VASCULAR TARGETING AGENT, COMBRETASTATIN A-4 PHOSPHATE, 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID, CANCER-THERAPY, NUDE-MICE, GROWTH, BLOOD, FLOW, RAT, ADENOCARCINOMA, Animals, Area Under Curve, Disease Models, Animal, Dose-Response Relationship, Drug, Fibrosarcoma, Magnetic Resonance Imaging, Mice, Necrosis, Organophosphorus Compounds, Pituitary Neoplasms, Prolactinoma, Rats, Regional Blood Flow, Tumor Markers, Biological, ZD6126, vascular targeting agents, MRI, tumour perfusion, response biomarker
SGUL Research Institute / Research Centre:	Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Neuroscience (INCCNS)
Journal or Publication Title:	BRITISH JOURNAL OF CANCER
ISSN:	0007-0920
Related URLs:	Author
Dates:	Date Event 19 May 2003 Published
Web of Science ID:	WOS:000183298700017
	Download EPMC Full text (PDF)
	Download EPMC Full text (HTML)
URI:	https://openaccess.sgul.ac.uk/id/eprint/1788
Publisher's version:	https://doi.org/10.1038/sj.bjc.6600926

Actions (login required)

Edit Item